Physician profile
Donna Wilson
NPI 1740309582
$213.75
in general payments reported to CMS, 2019-2025
7 companies · $90.76 in 2025
The $90.76 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.94 · 2021: $14.00 · 2023: $16.47 · 2024: $79.58 · 2025: $90.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.81 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $59.64 | 2024-2025 | Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $46.79 | 2024-2025 | Airsupra |
| Viiv Healthcare Company | $32.40 | 2023-2024 | Rukobia |
| Amgen INC. | $26.94 | 2020-2021 | |
| Pfizer INC. | $17.69 | 2024 | |
| Puma Biotechnology, INC. | $15.72 | 2025 | |
| Tersera Therapeutics LLC | $14.57 | 2025 | Zoladex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.